Last reviewed · How we verify
YAZ (SH T00186, BAY86-5300)
YAZ (SH T00186, BAY86-5300) is a Small molecule drug developed by Bayer. It is currently in Phase 3 development.
YAZ is a combination oral contraceptive that contains drospirenone and ethinyl estradiol, which work to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg.
At a glance
| Generic name | YAZ (SH T00186, BAY86-5300) |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Drospirenone, a progestin, has anti-androgenic and anti-mineralocorticoid effects, which contribute to its contraceptive efficacy. Ethinyl estradiol, an estrogen, helps to regulate the menstrual cycle and prevent ovulation.
Approved indications
Common side effects
Key clinical trials
- Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D (PHASE2)
- YAZ, Oral Contraceptive Registration in China (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- YAZ (SH T00186, BAY86-5300) CI brief — competitive landscape report
- YAZ (SH T00186, BAY86-5300) updates RSS · CI watch RSS
- Bayer portfolio CI
Frequently asked questions about YAZ (SH T00186, BAY86-5300)
What is YAZ (SH T00186, BAY86-5300)?
How does YAZ (SH T00186, BAY86-5300) work?
Who makes YAZ (SH T00186, BAY86-5300)?
What development phase is YAZ (SH T00186, BAY86-5300) in?
Related
- Manufacturer: Bayer — full pipeline
- Compare: YAZ (SH T00186, BAY86-5300) vs similar drugs
- Pricing: YAZ (SH T00186, BAY86-5300) cost, discount & access